25.74USD-0.64%Mkt Cap: 146.87B USDP/E: 19.67Last update: 2026-05-26
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The co…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap146.87B USD
Enterprise Value199.85B USD
Revenue (TTM)63.32B USD
Gross Profit46.51B USD
Net Income (TTM)7.77B USD
Revenue/Share11.13 USD
Last Price25.74 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS7170811035
Valuation
P/E (Trailing)19.67
P/E (Forward)9.15
PEG13.77
EV/EBITDA7.85
EV/Revenue3.16
P/S2.34
P/B1.71
EPS (TTM)1.31
EPS (Forward)2.84
52W Range
22.8849% of range28.75
52W High28.75 USD
52W Low22.88 USD
Profitability
Gross Margin74.33%
Oper. Margin31.62%
EBITDA Margin40.21%
Profit Margin12.42%
ROE8.99%
ROA3.73%
Growth
Revenue Growth5.40%
Earnings Growth-10.10%
Cash Flow & Leverage
Operating CF11.70B USD
CapEx (TTM)2.63B USD
FCF Margin19.55%
FCF Yield8.43%
Net Debt51.65B USD
Net Debt/EBITDA2.03
Balance Sheet
Debt/Equity0.74
Current Ratio1.25
Quick Ratio0.85
Book Value/Sh15.21 USD
Cash/Share2.295 USD
Dividends
Fwd Div Rate1.720 USD
Trail. Div Rate1.720 USD
Div. Yield6.63%
5Y Avg Yield5.01%
Payout Ratio131.30%
Ex-Div DateMay 8, 2026
Pay DateJun 12, 2026
Splits
Last Split1054:1000
Split DateNov 17, 2020
Analyst Consensus
Rating2.4 (Buy)
Target (Mean)29.19 USD
Target Range24.00 USD – 36.00 USD
# Analysts27
Ownership
Shares Out.5.70B
Float5.69B
Insiders0.10%
Institutions69.57%
Short Interest
Short Ratio4.0d
Short % Float2.46%
Short % Out.2.46%
Shares Short140.32M
Short (prev mo.)132.47M
Technical
SMA 5026.82 (-4.1%)
SMA 20025.79 (-0.2%)
Beta0.30
S&P 52W Chg28.31%
Avg Vol (30d)34.32M
Avg Vol (10d)34.08M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—